Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2
Clinical trial NCT01996267 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01996267
- Sponsor
- The Netherlands Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2018-12-01
- Enrollment
- 437
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.